Literature DB >> 23602226

The missing mass of morality: a new fitpack design for hepatitis C prevention in sexual partnerships.

Suzanne Fraser1.   

Abstract

In the West, most hepatitis C transmission occurs through the sharing of equipment used for injecting drugs, and most sharing occurs between sexual partners. Despite this, little is known about how injecting practice, including equipment use, is managed in these partnerships. This article draws on science studies theorist Bruno Latour's work on technology and ethics (2002), and preliminary data collected for a research project on sexual partners who inject together, to illuminate these issues. Responsibility for avoiding transmission has long been conceived individually, as have measures intended to aid individuals in fulfilling this responsibility, such as the distribution of sterile injecting equipment. This individualising tendency has been criticised for inequitably responsibilising disadvantaged people. This article aims to exceed this individualising approach by proposing a different understanding of agency and a new mode of prevention. Rather than treating hepatitis C in conventional terms, as a bounded, ontologically stable object that pre-exists its encounter with individuals and the material objects they use in injecting, it formulates it as made in its enfolding with other phenomena, including social relationships and technological objects. In turn it sees transmission in new terms; as a question of social relationships and of object design. The article goes on to discuss a new Australian research project that takes this approach as its starting point, aiming to develop two key prevention innovations: (1) new messages aimed at partnerships rather than individuals, and (2) a new injecting pack or 'fitpack' that treats the partnership as a primary unit of resourcing. The article concludes by considering the politics of this shift to an ethics of technology, social relationships and objects.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23602226     DOI: 10.1016/j.drugpo.2013.03.009

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  7 in total

1.  Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.

Authors:  Jade Boyd; Alexandra B Collins; Samara Mayer; Lisa Maher; Thomas Kerr; Ryan McNeil
Journal:  Addiction       Date:  2018-09-14       Impact factor: 6.526

2.  More than just someone to inject drugs with: Injecting within primary injection partnerships.

Authors:  Meghan D Morris; Anna Bates; Erin Andrew; Judith Hahn; Kimberly Page; Lisa Maher
Journal:  Drug Alcohol Depend       Date:  2015-09-30       Impact factor: 4.492

3.  The intersectional risk environment of people who use drugs.

Authors:  Alexandra B Collins; Jade Boyd; Hannah L F Cooper; Ryan McNeil
Journal:  Soc Sci Med       Date:  2019-06-22       Impact factor: 4.634

4.  (Re)shaping the self: An ethnographic study of the embodied and spatial practices of women who use drugs.

Authors:  Alexandra B Collins; Jade Boyd; Sandra Czechaczek; Kanna Hayashi; Ryan McNeil
Journal:  Health Place       Date:  2020-03-25       Impact factor: 4.078

5.  Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study.

Authors:  Alexandra B Collins; Jade Boyd; Kanna Hayashi; Hannah L F Cooper; Shira Goldenberg; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2019-12-27

6.  The role of gender and power dynamics in injection initiation events within intimate partnerships in the US-Mexico border region.

Authors:  Stephanie A Meyers; Laramie R Smith; Maria Luisa Mittal; Steffanie A Strathdee; Richard S Garfein; Andy Guise; Dan Werb; Claudia Rafful
Journal:  Cult Health Sex       Date:  2019-10-18

7.  Women's multiple uses of an overdose prevention technology to mitigate risks and harms within a supportive housing environment: a qualitative study.

Authors:  Geoff Bardwell; Taylor Fleming; Ryan McNeil; Jade Boyd
Journal:  BMC Womens Health       Date:  2021-02-02       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.